ECPC together with the European Organisation for Research and Treatment of Cancer (EORTC) contributed to the European Commission's public consultation on "Risk proportionate approaches in clinical trials" by providing joint reply to the Summary of Clinical Trial Results for Laypersons.

EORTC and ECPC are both interested in bringing timely and accurate clinical trials information to cancer patients so that they can make informed decisions. In view of their common interests in cancer patient information and education in clinical trials and cancer research, they decided to jointly comment to present consultation to show their common commitment.

 

Read full text of ECPC and EORTC joint contribution.

Download full text of the Summary of Clinical Trial Results for Laypersons.

Learn more about public consultation on "Risk proportionate approaches in clinical trials".